AU2019201045B2 — Systems, devices, and method for treating a sinus condition
Assigned to Intersect ENT Inc · Expires 2020-05-14 · 6y expired
What this patent protects
Docket No.: 577242001400 ABSTRACT Described here are systems, devices, and methods for delivery of an implant to a bodily cavity. The implant may include a hub and a plurality of legs, and may be moveable between a low profile and expanded configuration. The systems may includ…
USPTO Abstract
Docket No.: 577242001400 ABSTRACT Described here are systems, devices, and methods for delivery of an implant to a bodily cavity. The implant may include a hub and a plurality of legs, and may be moveable between a low profile and expanded configuration. The systems may include a crimping device having a crimping member with a plurality of arms. The plurality of arms may engage the plurality of legs of the implant, and may move the legs to move the implant to the low-profile configuration. In some instances a delivery device may aid in crimping and/or delivery of the implant. 44 pa-1633738 FIG. 1 207 100 102 208 204 112 104 ~210 103/0 206 308 200 300 302 304 202 214 306 212
Drugs covered by this patent
- Elocon (MOMETASONE FUROATE) · Merck & Co.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.